These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28460853)

  • 1. Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Agarwal N; Jain A; Mahmoud AN; Bishnoi R; Golwala H; Karimi A; Mojadidi MK; Garg J; Gupta T; Patel NK; Wayangankar S; Anderson RD
    Am J Med; 2017 Nov; 130(11):1280-1289. PubMed ID: 28460853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention-meta-analysis and meta-regression.
    Agarwal N; Mahmoud AN; Mojadidi MK; Golwala H; Elgendy IY
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1134-1139. PubMed ID: 30862490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis.
    Fortuni F; Ferlini M; Leonardi S; Angelini F; Crimi G; Somaschini A; Cornara S; Potenza A; De Servi S; Oltrona Visconti L; De Ferrari GM
    Int J Cardiol; 2018 Dec; 273():80-87. PubMed ID: 30115419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Bavishi C; Trivedi V; Singh M; Katz E; Messerli FH; Bangalore S
    Am J Med; 2017 Nov; 130(11):1325.e1-1325.e12. PubMed ID: 28623176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.
    Chen CF; Chen B; Zhu J; Xu YZ
    Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
    Atti V; Turagam MK; Garg J; Velagapudi P; Patel NJ; Basir MB; Mujer MT; Rayamajhi S; Abela GS; Koerber S; Gopinnathanair R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2460-2472. PubMed ID: 31432607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual versus triple antithrombotic therapy after percutaneous coronary intervention or acute coronary syndrome in patients with indication for anticoagulation: an updated meta-analysis.
    Shin D; Mohanty BD; Lee ES
    Coron Artery Dis; 2018 Dec; 29(8):670-680. PubMed ID: 30222595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
    Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Cavallari I; Patti G
    Am J Cardiol; 2018 Mar; 121(6):718-724. PubMed ID: 29373105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Versus Triple Therapy in Patients with Acute Coronary Syndrome and an Anticoagulation Indication: A Systematic Review with Meta-Analysis and Trial-Sequential Analysis.
    Gupta R; Malik AH; Gupta R; Ranchal P; Yandrapalli S; Patel B; Frishman WH; Aronow WS; Garg J
    Cardiol Rev; 2021 Sep-Oct 01; 29(5):245-252. PubMed ID: 34001690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Xing Z; Tang L; Zhu Z; Huang J; Peng X; Hu X
    Platelets; 2018 Sep; 29(6):589-595. PubMed ID: 28895771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.
    Lou B; Liang X; Wu Y; Deng Y; Zhou B; Yuan Z; She J
    Am J Cardiol; 2018 Aug; 122(4):604-611. PubMed ID: 30205887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Anticoagulants With Dual Antiplatelet Therapy Versus Clopidogrel in Patients After Percutaneous Coronary Intervention: A Meta-Analysis.
    Palla M; Briasoulis A; Kondur A
    Am J Ther; 2019; 26(1):e143-e150. PubMed ID: 27340910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
    Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
    Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis.
    Chen J; Wang LY; Deng C; Jiang XH; Chen TG
    Medicine (Baltimore); 2017 Sep; 96(37):e8015. PubMed ID: 28906384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis.
    Zhang J; Wang Z; Sang W; Wei M; Xu F; Chen Y
    Coron Artery Dis; 2019 Mar; 30(2):109-115. PubMed ID: 30629002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
    Barbieri L; Verdoia M; Schaffer A; Suryapranata H; De Luca G
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):611-622. PubMed ID: 27757726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.
    Zhang Y; Tang HQ; Li J; Fu ZX
    Chin Med J (Engl); 2013; 126(9):1750-4. PubMed ID: 23652062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of anti-thrombotic regimens in patients with percutaneous coronary intervention requiring oral anticoagulation: A traditional and network meta-analysis.
    Khan SU; Saleem MA; Abdullah A; Ghimire S; Lekkala M; Rahman H; Lone AN; Kaluski E
    Cardiovasc Revasc Med; 2017; 18(7):535-543. PubMed ID: 28457807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Effron MB; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):531-536. PubMed ID: 29360524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.